BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38141960)

  • 1. Patients with Long COVID continue to experience significant symptoms at 12 months and factors associated with improvement: A prospective cohort study in France (PERSICOR).
    Salmon D; Slama D; Linard F; Dumesges N; Le Baut V; Hakim F; Oustric P; Seyrat E; Thoreux P; Marshall E
    Int J Infect Dis; 2024 Mar; 140():9-16. PubMed ID: 38141960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
    Augustin M; Stecher M; Wüstenberg H; Di Cristanziano V; Sandaradura de Silva U; Picard LK; Pracht E; Rauschning D; Gruell H; Klein F; Wenisch C; Hallek M; Schommers P; Lehmann C
    Front Immunol; 2023; 14():1226622. PubMed ID: 37781408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.
    Hansen CB; Dvoncova K; Pérez-Alós L; Fogh K; Madsen JR; Garred CH; Jarlhelt I; Nielsen PB; Petersen SS; Fjordager CG; Lauritsen KT; Hilsted L; Boding L; Iversen KK; Hyveled L; Garred P
    J Intern Med; 2023 Jun; 293(6):763-781. PubMed ID: 37024264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Reported Long COVID and Its Association with the Presence of SARS-CoV-2 Antibodies in a Danish Cohort up to 12 Months after Infection.
    Fogh K; Larsen TG; Hansen CB; Hasselbalch RB; Eriksen ARR; Bundgaard H; Frikke-Schmidt R; Hilsted LM; Østergaard L; Johansen IS; Hageman I; Garred P; Iversen K
    Microbiol Spectr; 2022 Dec; 10(6):e0253722. PubMed ID: 36350150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study.
    Seeßle J; Waterboer T; Hippchen T; Simon J; Kirchner M; Lim A; Müller B; Merle U
    Clin Infect Dis; 2022 Apr; 74(7):1191-1198. PubMed ID: 34223884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study.
    Khanafer N; Henaff L; Bennia S; Termoz A; Chapurlat R; Escuret V; Proriol M; Duvert F; Mena C; Planckaert C; Trehet-Mandez N; Saadatian-Elahi M; Vanhems P
    Int J Environ Res Public Health; 2023 Aug; 20(17):. PubMed ID: 37681818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors.
    Gruber R; Montilva Ludewig MV; Weßels C; Schlang G; Jedhoff S; Herbrandt S; Mattner F
    BMC Infect Dis; 2024 Jan; 24(1):119. PubMed ID: 38262969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
    Augustin M; Schommers P; Stecher M; Dewald F; Gieselmann L; Gruell H; Horn C; Vanshylla K; Cristanziano VD; Osebold L; Roventa M; Riaz T; Tschernoster N; Altmueller J; Rose L; Salomon S; Priesner V; Luers JC; Albus C; Rosenkranz S; Gathof B; Fätkenheuer G; Hallek M; Klein F; Suárez I; Lehmann C
    Lancet Reg Health Eur; 2021 Jul; 6():100122. PubMed ID: 34027514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency, spectrum and risk factors of long COVID].
    Pink I; Welte T
    Inn Med (Heidelb); 2022 Aug; 63(8):813-818. PubMed ID: 35925071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.